lncRNANEAT1 inhibits the expression of miR-34a-5p and miR-204-5p, regulates ACSL4 by sponging miR-34a-5p and miR-204-5p, promotes doxorubicin resistance in PCa cells, and accelerates the progression of prostate cancer [151]. This evidence concerns the gene ACSL4 and prostate cancer.